Study Evaluating IMA-638 in Healthy Japanese

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate the safety and drug levels for single, ascending doses of IMA-638 in healthy Japanese subjects.

Key facts

Study ID

NCT00340327

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

Starts

2006-06-01

Expected to finish

2007-07-01

Last updated by the study team

2007-12-05

Who can join

Age: 20 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• First generation healthy Japanese men and women of non-childbearing potential.

Where it is running

• Study site — Glendale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.